Exelixis Inc (NASDAQ:EXEL) - Share price - Overview

Stock Report

Exelixis Inc EXEL

Last Price
$21.34

Day Change
0.01|0.05%

As of 19/07/2018
16:13:44 EDT | USD
Minimum 15 Minutes Delay.

Last Close21.33
Day Range21.14 - 21.62
Mkt Cap6.33Bil
52-Wk Range18.50 - 32.50
Yield %-
ISINUS30161Q1040
Volume2,580,267
P/E26.35
P/S11.43
P/CF39.63

Share Price

Financials
201520162017
More ...
Income Statement
Revenue37.17191.45452.48
Operating Income-120.38-27.21162.34
Net Income-169.74-70.22154.23
Basic EPS-0.81-0.280.52
Avg. Diluted Shares Outstanding209251312
Balance Sheet
Current Assets178.67470.80484.87
Non Current Assets153.68126.74170.42
Total Assets332.34597.54655.29
Current Liabilities52.25270.59115.17
Total Liabilities---
Total Equity-104.3089.32284.96
Cash Flow
Operating Cash Flow-141.59206.30165.61
Capital Expenditure-0.45-1.70-21.14
Free Cash Flow-142.03204.59144.47

In millions, except "Basic EPS". Currency is USD.

Company Profile

Exelixis Inc is a biotechnology company. It is involved in discovery, development, and commercialization of new medicines for people with cancer. The Cabometyx product generates maximum revenue for the company.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

372
Key Stats
More ...
Price/Earning TTM25.09
Price/Book9.45
Price/Sales TTM11.43
Rev Growth (3 year avg)162.17
EPS Growth (3 year avg)-
Operating Margin % TTM35.88
Net Margin % TTM34.09
ROE TTM82.22
Debt/Equity0.06
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.